Trans-allelic model for prediction of peptide:MHC-II interactions
A. M. Degoot, Faraimunashe Chirove, and Wilfred Ndifon

TL;DR
This paper introduces a trans-allelic prediction model for peptide-MHC-II interactions that combines peptide sequence and structural data, offering a physically interpretable approach with performance comparable to existing methods.
Contribution
The authors develop a generalized biophysical model for all three human MHC-II loci, integrating sequence and structural information to improve prediction and understanding of peptide binding.
Findings
Model achieves comparable performance to state-of-the-art methods.
Supports previous predictions about binding pocket contributions.
Identifies new significant roles for P4 and P5 pockets in HLA-DP.
Abstract
Major histocompatibility complex class two (MHC-II) molecules are trans-membrane proteins and key components of the cellular immune system. Upon recognition of foreign peptides expressed on the MHC-II binding groove, helper T cells mount an immune response against invading pathogens. Therefore, mechanistic identification and knowledge of physico-chemical features that govern interactions between peptides and MHC-II molecules is useful for the design of effective epitope-based vaccines, as well as for understanding of immune responses. In this paper, we present a comprehensive trans-allelic prediction model, a generalized version of our previous biophysical model, that can predict peptide interactions for all three human MHC-II loci (HLA-DR, HLA-DP and HLA-DQ), using both peptide sequence data and structural information of MHC-II molecules. The advantage of this approach over other…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · T-cell and B-cell Immunology · Immunotherapy and Immune Responses
